PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of California, 2121 Berkeley Way West, 5th floor, Berkeley, CA, 94720, USA. sfacente@berkeley.edu.\', \'Washington University in St. Louis, St. Louis, MO, USA.\', \'University of Minnesota, Minneapolis, MN, USA.\', \'University of Southern California, Los Angeles, CA, USA. jdklausner@med.usc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40265-021-01636-5
?:hasPublicationType
?:journal
  • Drugs
is ?:pmid of
?:pmid
?:pmid
  • 34851510
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.547
?:rankingScore_hIndex
  • 150
is ?:relation_isRelatedTo_publication of
?:title
  • Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all